Chicago Business

Chicago Business

AbbVie hits a speed bump with Parkinson's drug approval

AbbVie hits a speed bump with Parkinson's drug approval

Having trouble viewing this email? See the online version

Health Pulse Breaking News

Tuesday, June 25, 2024

AbbVie sign

AbbVie hits a speed bump with Parkinson's drug approval

A hoped-for successor to Duopa reached another snag with U.S. regulators over one of its third-party manufacturing facilities.

Did someone forward this to you? Sign up for Health Pulse breaking news alerts here and unlock access to the full story with a Health Pulse subscription.

UNLOCK YOUR ACCESS

Discover the latest insights, analysis & opinion needed to navigate Chicago's complex business landscape.

<![if !mso]> <![endif]>

VIEW OUR SUBSCRIPTION OFFERS

This email was sent to chicagobusinessus627@emails.newslettersbase.com
Manage My Account | Contact Us

© 2024 Crain Communications Inc
130 E. Randolph St., Suite 3200, Chicago, IL 60601 United States
Privacy Policy | Terms and Conditions | Unsubscribe

This email was sent

June 25, 2024 8:32pm
Country:

United States
Tags